Since summer 2023, physicians have recommended patients taking GLP-1s, such as Ozempic or Mounjaro, to skip a dose before an elective surgery. Researchers from Stanford Medicine say this might be unnecessary and create adverse effects.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
